Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference
Rhea-AI Summary
Anika Therapeutics (NASDAQ: ANIK), a global joint preservation company focusing on early intervention orthopedics, has announced that its President and CEO, Dr. Cheryl Blanchard, will be presenting at the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego.
The presentation is scheduled for Monday, March 10, 2025, at 2:30 PM PT / 5:30 PM ET. In addition to the presentation, Anika's management team will be participating in one-on-one investor meetings throughout the event.
Interested parties can access a live webcast of the presentation on the Events and Webcasts page under the Investors section of Anika's website. The presentation will remain archived on the site for 30 days afterward. Investors seeking to schedule meetings with Anika's senior management during the conference can contact the company's Investor Relations department at investorrelations@anika.com.
Positive
- Anika's participation in the Canaccord Genuity Conference demonstrates their active engagement with the investment community
- The company's focus on joint preservation and early intervention orthopedics positions them in a growing healthcare segment
- Management's availability for one-on-one meetings suggests openness to investor communication
Negative
- The press release doesn't provide specific information about Anika's financial performance or business updates
- No details about the content of the upcoming presentation were shared
- Investors may need to wait until the conference to learn about any new company developments
News Market Reaction – ANIK
On the day this news was published, ANIK gained 1.61%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
BEDFORD, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and CEO of Anika, will present at the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego on Monday, March 10, 2025 at 2:30pm PT / 5:30pm ET. Management will also participate in one-on-one investor meetings throughout the event.
The presentation will be webcast live on the Events and Webcasts page under the Investors section of Anika Therapeutics’ website and will be archived for 30 days following the presentation. For more information about this event or to schedule a one-on-one meeting with Anika’s senior management, please contact Anika’s Investor Relations at investorrelations@anika.com.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS, CINGAL, HYALOFAST, INTEGRITY, MONOVISC, ORTHOVISC, TACTOSET, and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc. for its use.
For Investor Inquiries:
Anika Therapeutics, Inc.
Matt Hall, 781-457-9554
Director, Corporate Development and Investor Relations
investorrelations@anika.com
FAQ
When will Anika Therapeutics (ANIK) present at the Canaccord Genuity 2025 Musculoskeletal Conference?
How can investors watch Anika's (ANIK) presentation at the Canaccord Genuity Conference?
Will Anika Therapeutics (ANIK) management be available for investor meetings at the Canaccord Conference?
What is Anika Therapeutics' (ANIK) business focus according to their March 2025 conference announcement?
Who will represent Anika Therapeutics (ANIK) at the Canaccord Genuity 2025 Musculoskeletal Conference?
